A comparative study of detection of p53 mutations in human breast cancer by flow cytometry, single-strand conformation polymorphism and genomic sequencing
1996

Comparative Study of p53 Mutations in Breast Cancer

Sample size: 110 publication Evidence: moderate

Author Information

Author(s): G Chakravarty, A Redkarl, I Mittra

Primary Institution: Tata Memorial Hospital

Hypothesis

How closely do p53 mutations detected by different methods correlate with each other?

Conclusion

The study found good concordance between mutations detected by PCR-SSCP and genomic sequencing, but immunochemical detection of p53 overexpression is not a reliable indicator of p53 gene mutation.

Supporting Evidence

  • 64% of the breast tumors were found to be immunopositive for p53.
  • 11 out of 15 immunopositive tumors had mutations detected by PCR-SSCP.
  • 96.5% concordance was found between PCR-SSCP and genomic sequencing.

Takeaway

Scientists looked at breast cancer samples to see if a protein called p53 was mutated. They found that just because the protein was present, it didn't always mean there was a mutation.

Methodology

The study used flow cytometry, PCR-SSCP, and genomic sequencing to analyze p53 mutations in breast cancer tissues.

Limitations

The study's findings may not apply to all breast cancer cases, as it focused on a specific subset of tumors.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication